DSC management and support. April 15, 2026 through november 30, 2027 N01DA-22-2253, task order no. 75N98026F00001 (to 29) "collaborative care for polysubstance use in primary care settings (CO-care)"
Active Awarded Last action
- Contract number
- 75N98026F00001
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Obligated
- $669,860
Award facts
- Contract value 100% obligated
- $669,860.39 Current and potential, with all options
- Completion date 32% complete
- Current and potential, with all options
- Funding agency
- National Institute on Drug Abuse National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The National Institute on Drug Abuse awarded a task order valued at $669,860.39 to The Emmes Company, LLC for the "Collaborative Care for Polysubstance Use in Primary Care Settings (CO-CARE)" initiative. This delivery order, issued on April 17, 2026, runs through November 30, 2027, and represents Task Order No. 75N98026F00001 under the NIDA Data, Statistics, and Clinical Trial Support Center master contract. The work will be performed in Rockville, Maryland, where Emmes maintains its headquarters. This award utilizes a cost-plus-fixed-fee pricing structure with no set-aside designation, indicating Emmes competed on an open basis for this opportunity.
The task order falls under the larger $31.2 million NIDA Data, Statistics, and Clinical Trial Support Center indefinite delivery vehicle, which enables Emmes to provide flexible research support across multiple substance abuse initiatives. Emmes, a leading clinical research organization specializing in biostatistical analysis, data management, and clinical trial coordination, will support NIDA's efforts to address polysubstance use disorders through integrated care models in primary care settings. The company's established expertise in managing complex federal clinical research programs and its existing partnership with NIDA through the broader IDV position it to effectively deliver the data coordination, statistical analysis, and clinical support services required for this collaborative care initiative.
Quick answers
Who was awarded contract 75N98026F00001?
75N98026F00001 was awarded to The Emmes Company, LLC by Office of Logisitics and Acquisition Operations (National Institutes of Health) on April 17, 2026.
How much is contract 75N98026F00001 worth?
The government has obligated $669,860 on 75N98026F00001.
Which agency awarded contract 75N98026F00001?
Office of Logisitics and Acquisition Operations (National Institutes of Health) awarded 75N98026F00001, with funding from National Institute on Drug Abuse (National Institutes of Health).
Is contract 75N98026F00001 an order under another contract?
Yes. 75N98026F00001 is a delivery order under 75N95022D00017, an indefinite delivery contract.
Was contract 75N98026F00001 competed?
The extent of competition for 75N98026F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award